Premium
Barely a fortnight after exiting Natco Pharma Ltd with stellar returns, homegrown private equity firm CX Partners has made a lucrative exit from yet another healthcare firm, almost six years after backing it.According to stock exchange data, CX Partners has sold its remaining shares worth Rs 75-80 crore in diagnostics ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
